medigraphic.com
ISSN 1561-2996 (Electronic)
ISSN 0864-0289 (Print)

2019, Number 3

<< Back Next >>

Rev Cubana Hematol Inmunol Hemoter 2019; 35 (3)

Blood products in the emergency room: vital treatment for polytraumatized patients

Martinez Sanchez, Lina Maria; Hernández-Martínez, Alejandro; Roldan-Tabares, Mabel Dahiana; Herrera-Almanza, Laura; Villegas-Alzate, Juan Diego; Álvarez-Hernández, Luis Felipe

Language: Spanish
References: 64
Page: 1-20
PDF size: 231.57 Kb.


ABSTRACT

Introduction: The main cause of early mortality in polytrauma patients is hypovolemia secondary to massive hemorrhage. Hemocomponent and crystalloid therapy is an essential and life-saving mechanism in these situations as a measure of volume replacement. In the same way, patients with severe traumatic injuries have a significant acute decrease in circulating platelet counts that makes them candidates for transfusion of platelet components; However, the use of these blood components can lead to unwanted outcomes such as increased mortality. Although many studies reveal an increase in mortality as an outcome associated with the use of blood components, others establish its use as a reducing measure of this outcome. Objective: to present the main indications of blood components in polytrauma patients, as well as to relate the adverse events associated with their use that influence the mortality and hospitalization time of these patients. Devlopment: Mortality associated with the use of blood components is still a controversial issue. In massive hemorrhage, rapid and efficient transfusion support is essential in the treatment and care of polytrauma, hence it is necessary to have transfusion protocols that improve results and reduce complications. In addition, the need for new studies on the subject to improve these protocols and reduce complications was identified.


REFERENCES

  1. Navarro S, Koob M, Orregoc C, Muñoz-Vivesd JM, Rivero M, Montmanya S, et al. Estudio para la mejoría de la atención hospitalaria inicial del paciente politraumatizado: proyecto TRAUMACAT. MedClin (Barc). 2014;143(Supl 1):25-31. DOI: 10.1016/j.medcli.2013.07.001

  2. Gosselin RA, Spiegel DA, Coughlin R, Zirkle LG. Injuries: the neglected burden in developing countries. Bulletin of theWorldHealthOrganization 2009;87:246. DOI: 10.2471/BLT.08.052290

  3. Motameni AT, Hodge RA, McKinley WI, Georgel JM, Strollo BP, Benns MV, et al. The use of ABC score in activation of massive transfusion: The yin and the yang. J Trauma Acute Care Surg. 2018 ;85(2):298-302. DOI:10.1097/TA.0000000000001949.

  4. Hwang K, Kwon J, Cho J, Heo Y, Lee JC, Jung K. Implementation of Trauma Center and Massive Transfusion Protocol Improves Outcomes for Major Trauma Patients: A Study at a Single Institution in Korea. World J Surg. 2018;42(7):2067-2075. DOI: 10.1007/s00268-017-4441-5.

  5. Guerado E, Medina A, Mata MI, Galvan JM, Bertrand ML. Protocols for massive blood transfusion: when and why, and potential complications. Eur J Trauma Emerg Surg. 2016;42(3):283-95. DOI: 10.1007/s00068-015-0612-y

  6. Rapsang AG, Shyam DC. Compendio de las escalas de evaluación de riesgo en el paciente politraumatizado. Cir esp. 2015; 93(4):213-21. DOI:10.1016/j.ciresp.2013.12.021.

  7. Guerrero GM, Andrighetti LG. Reposición de volumen en el politraumatizado.Rev. Med. Clin. Condes. 2011; 22(5) 599-606.DOI:10.1016/S0716-8640(11)70471-0.

  8. Schroll R, Swift D, Tatum D, Couch S, Heaney JB, Llado-Farrulla M, et al. Accuracy of shock index versus ABC score to predict need for massive transfusion in trauma patients. Injury. 2018;49(1):15-19. DOI: 10.1016/j.injury.2017.09.015.

  9. Stanworth SJ, Davenport R, Curry N, Seeney F, Eaglestone S, Edwards A, et al. Mortality from trauma haemorrhage and opportunities for improvement in transfusion practice. Br J Surg. 2016;103(4):357-65. DOI: 10.1002/bjs.10052.

  10. Bochicchio GV, Napolitano L, Joshi M, Bochicchio K, Meyer W, ScaleaTM.Outcome analysis of blood product transfusion in trauma patients: a prospective, risk-adjusted study. World J Surg. 2008;32(10):2185-9. DOI:10.1007/s00268-008-9655-0.

  11. Anaya González J, Cruz Alonso J, Anaya González H, García Rodríguez Y, Rodríguez Esquijarosa Y. Manejo del paciente politraumatizado en la atención primaria de salud. Rev Científ Fac Ciencias Salud. 2015 Jul-Dic; 2(2): 9-16.

  12. Global Health Estimates [Internet]. World Health Organization. 2018 [citado 13 agosto 2018]. Disponible en: http://www.who.int/healthinfo/global_burden_disease/en/

  13. Cortés MC, Acuña RL, Álvarez M F, Álvarez L N. Manejo inicial del politraumatizado. Rev Hosp Clín Univ Chile 2013; 25: 206 - 16

  14. WHO | Global status report on road safety 2015 [Internet]. WHO. [citado el 31 de agosto de 2018]. Disponible en: http://www.who.int/violence_injury_prevention/road_safety_status/2015/en/

  15. Mackenzie EJ, Rivara FP, Jurkovich GJ, Nathens AB, Frey KP, Egleston BL, et al. The National Study on Costs and Outcomes of Trauma. J Trauma. 2007; 63(6 Suppl):S54-67. DOI: 10.1097/TA.0b013e31815acb09

  16. 16 Ten Leading Causes of Death and Injury - PDFs|InjuryCenter|CDC [Internet]. 2018 [citado el 13 de agosto de 2018]. Disponible en: https://www.cdc.gov/injury/wisqars/LeadingCauses.html

  17. Ministerio de Salud y Protección Social. ANALISIS DE SITUACIÓN DE SALUD (ASIS) COLOMBIA, 2016. Bogotá: Imprenta Nacional de Colombia; 2016 p. 1-163.

  18. Teixeira PG, Inaba K, Hadjizacharia P, Brown C, Salim A, Rhee P, et al. Preventable or potentially preventable mortality at a mature trauma center. J Trauma. 2007;63(6):1338-46; discussion 1346-7. DOI: 10.1097/TA.0b013e31815078ae.

  19. Evans JA, van Wessem KJ, McDougall D, Lee KA, Lyons T, Balogh ZJ. Epidemiology of traumatic deaths: comprehensive population-based assessment. World J Surg. 2010;34(1):158-63. DOI: 10.1007/s00268-009-0266-1.

  20. Olarte CM, Nossa JM, Villarroel Méndez G, Mejía Á, Segura O. Efecto de la transfusión sanguínea en la mortalidad en politraumatismo. Rev Colomb Ortop Traumatol. 2015;29(2):43–8. DOI: 10.1016/j.rccot.2016.01.002

  21. Alimohammadi H, Kianian Y, Zerepoosh FB, Derakhshanfar H, Alavi-Moghadam M, Hatamabadi HR, et al. Accuracy of emergency transfusion score in prediction need for blood transfusion among multiple trauma patients: A cross-sectional study from Iran. Int J CritIllnInj Sci. 2017;7(4):248-251. DOI: 10.4103/IJCIIS.IJCIIS_118_16.

  22. Perel P, Prieto-Merino D, Shakur H, Clayton T, Lecky F, Bouamra O, et al. Predicting early death in patients with traumatic bleeding: development and validation of prognostic model. BMJ 2012; 345 :e5166. DOI: 10.1136/bmj.e5166.

  23. Flores-Torrecillas R, Carballo-Monreal MR, Alvarez-Villaseñor AS, Valdez-Márquez ML, González-Ojeda A, et al. Manejo y administración de hemoderivados por personal de enfermería en un hospital de segundo nivel. Enferm Univ. 2014;11(3):94–100.DOI: 10.1016/S1665-7063(14)72672-7

  24. Mitra B, Nash JL, Cameron PA, Fitzgerald MC, Moloney J, Velmahos GC. Potentially avoidable blood transfusion during trauma resuscitation. Injury. 2015 ;46(1):10-4. DOI: 10.1016/j.injury.2014.08.050.

  25. Arya RC, Wander G, Gupta P. Blood component therapy: Which, when and how much. J Anaesthesiol Clin Pharmacol. 2011;27(2):278-84. DOI: 10.4103/0970-9185.81849.

  26. Peralta R, Vijay A, El-Menyar A, Consunji R, Afifi I, Mahmood I, Asim M, et al. Early high ratio platelet transfusion in trauma resuscitation and its outcomes. Int J Crit Illn Inj Sci. 2016;6(4):188-193. DOI: 10.4103/2229-5151.195448 27. Boutefnouchet T, Gregg R, Tidman J, Isaac J, Doughty H. Emergency red cellsfirst: Rapid response or speed bump? The evolution of a massive transfusion protocol for trauma in a single UK centre. Injury. 2015;46(9):1772-8. DOI: 10.1016/j.injury.2015.05.046.

  27. Peralta R, Vijay A, El-Menyar A, Consunji R, Abdelrahman H, Parchani A, et al. Trauma resuscitation requiring massivetransfusion: a descriptive analysis of the role of ratio and time. World J Emerg Surg. 2015;10:36. DOI: 10.1186/s13017-015-0028-3.

  28. Hendrickson Hendrickson JE, Shaz BH, Pereira G, Parker PM, Jessup P, Atwell F, et al. Implementation of a pediatric trauma massive transfusion protocol: one institution's experience. Transfusion. 2012;52(6):1228-36. DOI: 10.1111/j.1537-2995.2011.03458.x.

  29. Sharma S, Sharma P, Tyler LN. Transfusion of blood and blood products: indications and complications. Am Fam Physician. 2011, 15;83(6):719-24.

  30. Practice Guidelines for blood component therapy: A report by the American Society of Anesthesiologists Task Force on Blood Component Therapy. Anesthesiology. 1996; 84(3):732-47. DOI: 10.1097/00000542-199603000-00032

  31. Larrondo M, Figueroa G. Terapia transfusional: criterios de indicaciones de componentes sanguíneos. Rev. Hosp. Clín. Univ. Chile 2007; 18; 208–19.

  32. Maegele M, Lefering R, Paffrath T, Tjardes T, Simanski C, Bouillon B; Working Group on Polytrauma of the German Society of Trauma Surgery (DGU). Red-blood-cell to plasma ratios transfused during massive transfusion are associated with mortality in severe multiple injury: a retrospective analysis from the Trauma Registry of the Deutsche Gesellschaft für Unfall chirurgie. Vox Sang. 2008;95(2):112-9. DOI: 10.1111/j.1423-0410.2008.01074.x.

  33. Schöchl H, Grassetto A, Schlimp CJ. Management of hemorrhage in trauma. J Cardiothorac VascAnesth. 2013;27(4 Suppl):S35-43. DOI: 10.1053/j.jvca.2013.05.015.

  34. Peiniger S, Nienaber U, Lefering R, Braun M, Wafaisade A, Wutzler S, et al; Trauma Registry of the Deutsche Gesellschaft für Unfallchirurgie. Balanced massive transfusion ratios in multiple injury patients with traumatic brain injury. Crit Care. 2011;15(1):R68. DOI: 10.1186/cc10048.

  35. Dirks J, Jørgensen H, Jensen CH, Ostrowski SR, Johansson PI. Blood product ratio in acute traumatic coagulopathy-effect on mortality in a Scandinavian level 1 trauma centre. Scand J Trauma Resusc Emerg Med. 2010 7;18:65. DOI:10.1186/1757-7241-18-65.

  36. Rossaint R, Bouillon B, Cerny V, Coats TJ, Duranteau J, Fernández-MondéjarE, et al. The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition. Crit Care. 2016;20:100. DOI: 10.1186/s13054-016-1265-x.

  37. Mitra B, Mori A, Cameron PA, Fitzgerald M, Paul E, Street A. Fresh frozen plasma (FFP) use during massive blood transfusion in trauma resuscitation. Injury. 2010;41(1):35-9. DOI: 10.1016/j.injury.2009.09.029.

  38. Sambasivan CN, Kunio NR, Nair PV, Zink KA, Michalek JE, Holcomb JB, et al. High ratios of plasma and platelets to packed red blood cells do not affect mortality in non massively transfused patients. J Trauma. 2011;71(2Suppl3):S329-36. DOI: 10.1097/TA.0b013e318227edd3.

  39. Seghatchian J, Samama MM. Massive transfusion: an overview of the maincharacteristics and potential risks associated with substances used forcorrection of a coagulopathy. Transfus Apher Sci. 2012;47(2):235-43. DOI: 10.1016/j.transci.2012.06.001.

  40. Khan S, Allard S, Weaver A, Barber C, Davenport R, Brohi K. A majorhaemorrhage protocol improves the delivery of blood component therapy and reduces waste in trauma massive transfusion. Injury. 2013;44(5):587-92. DOI:10.1016/j.injury.2012.09.029.

  41. Scher CS. Trauma and transfusion in the geriatric patient. Curr Opin Anaesthesiol. 2018;31(2):238-42. DOI: 10.1097/ACO.0000000000000556

  42. McCully BH, Underwood SJ, Kiraly L, Holcomb JB, Robinson BRH, Minei JP, et al. The effects of cryopreserved red blood cell transfusion on tissue oxygenation in obese trauma patients. J Trauma Acute Care Surg. 2018; 84(1):104-11. DOI: 10.1097/TA.0000000000001717.

  43. Napolitano L. Cumulative risks of early red blood cell transfusion. J Trauma. 2006;60(6):26-34. DOI: 10.1097/01.ta.0000199979.95789.17

  44. Liu S, Fujii Q, Serio F, McCague A. Massive Blood Transfusions and Outcomes in Trauma Patients; An Intention to Treat Analysis. Bull Emerg Trauma. 2018;6(3):217-220. DOI: 10.29252/beat-060305.

  45. Green L, Tan J, Grist C, Kaur M, MacCallum P. Aetiology and outcome of massive transfusion in two large London teaching hospitals over a 3-year period (2012-2014). Transfus Med. 2017;27(5):342-347. DOI: 10.1111/tme.12434.2

  46. Lim G, Harper-Kirksey K, Parekh R, Manini AF. Efficacy of a massive transfusion protocol for hemorrhagic trauma resuscitation. Am J Emerg Med. 2018;36(7):1178-81. DOI: 10.1016/j.ajem.2017.11.060.

  47. Mitra B, Olaussen A, Cameron PA, O'Donohoe T, Fitzgerald M. Massive blood transfusions post trauma in the elderly compared to younger patients.Injury. 2014;45(9):1296-300. DOI: 10.1016/j.injury.2014.01.016.

  48. Kutcher ME, Kornblith LZ, Narayan R, Curd V, Daley AT, Redick BJ, et al. A paradigm shift in trauma resuscitation: evaluation of evolving massive transfusion practices. JAMA Surg. 2013;148(9):834-40. DOI: 10.1001/jamasurg.2013.2911.

  49. Kim Y, Lee K, Kim J, Kim J, Heo Y, Wang H, et al. Application of damage control resuscitation strategies to patients with severe traumatic hemorrhage: review of plasma to packed red blood cell ratios at a single institution. J Korean Med Sci. 2014;29(7):1007-11. DOI: 10.3346/jkms.2014.29.7.1007.

  50. Endo A, Shiraishi A, Fushimi K, Murata K, Otomo Y. Outcomes of patients receiving a massive transfusion for major trauma. Br J Surg. 2018 Oct;105(11):1426-1434. DOI: 10.1002/bjs.10905.

  51. Rahouma M, Kamel M, Jodeh D, Kelley T, Ohmes LB, de Biasi AR, et al. Does a balanced transfusion ratio of plasma to packed red blood cells improve outcomes in both trauma and surgical patients? A meta-analysis of randomized controlled trials and observational studies. Am J Surg. 2018 Aug;216(2):342-350. DOI: 10.1016/j.amjsurg.2017.08.045.

  52. Rahbar E, Cardenas JC, Matijevic N, Del Junco D, Podbielski J, Cohen MJ, et al. Trauma, Time, and Transfusions: A Longitudinal Analysis of Coagulation Markers in Severely Injured Trauma Patients Receiving Modified Whole Blood or Component Blood Products. Shock. 2015;44(5):417-25. DOI: 10.1097/SHK.0000000000000449.

  53. Kornblith LZ, Kutcher ME, Redick BJ, Calfee CS, Vilardi RF, Cohen MJ. Fibrinogen and platelet contributions to clot formation: implications for trauma resuscitation and thromboprophylaxis. J Trauma Acute Care Surg. 2014;76(2):255-6 DOI: 10.1097/TA.0000000000000108.

  54. Henriksen HH, Grand AG, Viggers S, Baer LA, Solbeck S, Cotton BA, et al. Impact of blood products on platelet function in patients with traumatic injuries: a translational study. J Surg Res. 2017;214:154-161. DOI: 10.1016/j.jss.2017.02.037.

  55. Ponschab M, Schlimp CJ, Zipperle J, Gabriel C, Süssner S, Cadamuro J, et al. Platelet function in reconstituted whole blood variants: An observational study over 5 days of storage time. J Trauma Acute Care Surg. 2015;79(5):797-804. DOI: 10.1097/TA.0000000000000852.

  56. Aubron C, Flint AWJ, Ozier Y, McQuilten Z. Platelet storage duration and its clinical and transfusion outcomes: a systematic review. Crit Care. 2018;22(1):185. DOI: 10.1186/s13054-018-2114-x

  57. Spadaro S, Reverberi R, Fogagnolo A, Ragazzi R, Napoli N, Marangoni E, etal.Transfusion of stored red blood cells in critically ill trauma patients: a retrospective study. Eur Rev Med Pharmacol Sci. 2015;19(14):2689-96.

  58. Green RS, Erdogan M, Lacroix J, Hébert PC, Tinmouth AT, Sabri E, et al. Age of transfused blood in critically ill adult trauma patients: a prespecified nested analysis of the Age of Blood Evaluation randomized trial. Transfusion. 2018 Aug;58(8):1846-54. DOI: 10.1111/trf.14640.

  59. Orlov D, Karkouti K. The pathophysiology and consequences of red blood cell storage. Anaesthesia. 2015;70(1):29-37. DOI: 10.1111/anae.12891.

  60. Jones AR, Frazier SK. Consequences of Transfusing Blood Components in Patients With Trauma: A Conceptual Model. Crit Care Nurse. 2017;37(2):18-30. DOI: 10.4037/ccn2017965.

  61. Nguyen KA1, Hamzeh-Cognasse H1, Sebban M2, Fromont E2, Chavarin P3, Absi L, et al. A computerized prediction model of hazardous inflammatory platelet transfusion outcomes. PLoS One. 2014;9(5):e97082. DOI: 10.1371/journal.pone.0097082.

  62. Kasotakis G, Starr N, Nelson E, Sarkar B, Burke PA, Remick DG, et al. Platelet transfusion increases risk for acute respiratory distress syndrome in non-massively transfused blunt trauma patients. Eur J Trauma Emerg Surg. 2018. DOI: 10.1007/s00068-018-0953-4.

  63. Wegner A, Pacheco S, Céspedes P, Guevara R, Mallea L, Darras E, et al. Enfermedad injerto contra huésped asociada a transfusión. Rev Chil Pediatr 2007; 78 (5): 500-510 http://dx.doi.org/10.4067/S0370-41062007000500008 65. Carson JL, Triulzi DJ, Ness PM. Indications for and Adverse Effects of Red-Cell Transfusion. N Engl J Med. 2017;377(13):1261-1272. DOI:10.1056/NEJMra1612789.

  64. Davenport RD, Bluth MH. Hemolytic transfusion reactions. In: Simon TL, McCullough J, Snyder EL, Solheim BG, Strauss RG, eds. Rossi’s principles of transfusion medicine. 5th ed. West Sussex, United Kingdom: Wiley-Blackwell, 2016:642-51.




2020     |     www.medigraphic.com